会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 22. 发明申请
    • IMAGING NEUROINFLAMMATION
    • 成像神经炎症
    • US20110190618A1
    • 2011-08-04
    • US13119450
    • 2009-10-02
    • Harry John WadsworthBo ShanDennis O' SheaJoanna Marie PassmoreWilliam John Trigg
    • Harry John WadsworthBo ShanDennis O' SheaJoanna Marie PassmoreWilliam John Trigg
    • A61B6/00C07D495/04A61K51/00A61B19/00
    • C07D495/04A61K51/0446
    • The present invention concerns in vivo imaging and in particular in vivo imaging of the peripheral benzodiazepine receptor (PBR). A tetracyclic indole in vivo imaging agent is provided that binds with high affinity to PBR, has good uptake into the brain following administration, and which preferentially binds to tissues expressing higher levels of PBR. The present invention also provides a precursor compound useful in the synthesis of the in vivo imaging agent of the invention, as well as a method for synthesis of said in vivo imaging agent comprising use of said precursor compound, and a kit for carrying out said method. A cassette for the automated synthesis of the in vivo imaging agent is also provided. In addition, the invention provides a radiopharmaceutical composition comprising the in vivo imaging agent of the invention, as well as methods for the use of said in vivo imaging agent.
    • 本发明涉及体内成像,特别是周边苯二氮卓受体(PBR)的体内成像。 提供四环吲哚体内显像剂,其以高亲和力与PBR结合,在给药后具有良好的摄入脑中,并优先结合表达较高水平的PBR的组织。 本发明还提供了可用于合成本发明的体内显像剂的前体化合物,以及包含使用所述前体化合物的所述体内显像剂的合成方法和用于实施所述方法的试剂盒 。 还提供了用于体内成像剂的自动合成的盒。 此外,本发明提供了包含本发明的体内显像剂的放射性药物组合物,以及使用所述体内显像剂的方法。
    • 25. 发明授权
    • Imaging neuroinflammation
    • 成像神经炎症
    • US09481685B2
    • 2016-11-01
    • US13119450
    • 2009-10-02
    • Harry John WadsworthBo ShanDennis O'SheaJoanna Marie PassmoreWilliam John Trigg
    • Harry John WadsworthBo ShanDennis O'SheaJoanna Marie PassmoreWilliam John Trigg
    • A61K51/00A61M36/14C07D495/04A61K51/04
    • C07D495/04A61K51/0446
    • The present invention concerns in vivo imaging and in particular in vivo imaging of the peripheral benzodiazepine receptor (PBR). A tetracyclic indole in vivo imaging agent is provided that binds with high affinity to PBR, has good uptake into the brain following administration, and which preferentially binds to tissues expressing higher levels of PBR. The present invention also provides a precursor compound useful in the synthesis of the in vivo imaging agent of the invention, as well as a method for synthesis of said in vivo imaging agent comprising use of said precursor compound, and a kit for carrying out said method. A cassette for the automated synthesis of the in vivo imaging agent is also provided. In addition, the invention provides a radiopharmaceutical composition comprising the in vivo imaging agent of the invention, as well as methods for the use of said in vivo imaging agent.
    • 本发明涉及体内成像,特别是周边苯二氮卓受体(PBR)的体内成像。 提供四环吲哚体内显像剂,其以高亲和力与PBR结合,在给药后具有良好的摄入脑中,并优先结合表达较高水平的PBR的组织。 本发明还提供了可用于合成本发明的体内显像剂的前体化合物,以及包含使用所述前体化合物的所述体内显像剂的合成方法和用于实施所述方法的试剂盒 。 还提供了用于体内成像剂的自动合成的盒。 此外,本发明提供了包含本发明的体内显像剂的放射性药物组合物,以及使用所述体内显像剂的方法。
    • 30. 发明授权
    • N4 chelator conjugates
    • N4螯合剂共轭物
    • US07767796B2
    • 2010-08-03
    • US11572161
    • 2005-07-19
    • Anthony Eamonn StoreyHarry John WadsworthNigel Anthony PowellPhilip Duncanson
    • Anthony Eamonn StoreyHarry John WadsworthNigel Anthony PowellPhilip Duncanson
    • C07F13/00
    • A61K51/0478A61K51/0497
    • The present invention provides tetra-amine chelator conjugates with biological targeting moieties, linked via a linker group and technetium complexes thereof as radiopharmaceuticals. The linker group is such that the chelator is mono-functionalized at the bridgehead position and provides both flexibility and a lack or aryl groups, to minimize lipophilicity and steric hulk. Protected versions of the chelators are provided which permit conjugation with a wide range of targeting molecules without interfering reactions with the amine nitrogens of the tetra-amine chelator. Syntheses of the functionalised chelators are described, together with bifunctional chelate precursors. Radiopharmaceutical compositions comprising the technetium metal complexes of the invention are described, together with non-radioactive kits for the preparation of such radiopharmaceuticals.
    • 本发明提供四胺螯合剂与生物靶向部分,通过连接基团和其锝络合物作为放射性药物连接。 接头基团使得螯合剂在桥头位置被单官能化并且提供柔性和缺乏或芳基,以使亲脂性和空间巨大的最小化。 提供了螯合剂的保护形式,其允许与宽范围的靶向分子缀合,而不与四胺螯合剂的胺氮化物发生干扰反应。 描述了官能化螯合剂的合成以及双官能螯合物前体。 本发明描述了包含本发明的锝金属络合物的放射性药物组合物,以及用于制备这种放射性药物的非放射性试剂盒。